Company / Working Capital per Share
10x Genomics, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.34
FY2025
5-year range
$3.92 / $5.87
FY2021-FY2025
Trend
+10.8%
vs FY2024
Sector context
#95 of 163
Health Care
What the data says
At $4.34, 10x Genomics, Inc.'s working capital per share ranks #95 of 163 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 5 years of decline, reaching $4.34.
Based on SEC 10-K filings.
4.34 in FY2025 with a 5-year CAGR of -8.6%.
Improved from $4.07 to $4.34 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -8.6%
- 10-Year CAGR
- -
Sector benchmark
#95 of 163 in Health CareTop 58% of 163This company $4.34 Sector average $23.91
▼
-81.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 10.8% year-over-year.
- Ranks #95 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.34 | +10.8% |
| FY2024 | $3.92 | -3.7% |
| FY2023 | $4.07 | -9.2% |
| FY2022 | $4.48 | -23.7% |
| FY2021 | $5.87 | -13.9% |
| FY2020 | $6.82 | -76.3% |
| FY2019 | $28.71 | +420.6% |
| FY2018 | $5.52 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026